Actualites Pharmaceutiques

eISSN: 0515-3700 pISSN: 0515-3700

Key Metrics

0.1
CiteScore
Q4 Pharmacology
SJR
0.15
SNIP

Indexed in the following public directories

  • Web of Science
  • Scopus
  • SJR

Journal Specifications

Overview
Publisher ELSEVIER MASSON, CORPORATION OFFICE
Language French
Frequency Monthly
General Details
Language French
Frequency Monthly
Publication Start Year 1961
Publisher URL Visit website
Website URL Visit website

Planning to publish in Actualites Pharmaceutiques ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers

Scite analysis

Powered by scite_

4.1k articles received 308 citations see all

  • 4 Supporting
  • 238 Mentioning
  • 0 Contrasting

Editorial notices

  • 0 Retractions
  • 0 Withdrawals
  • 0 Corrections
  • 3 Errata
  • 0 Expression of Concern

FAQs

How long has Actualites Pharmaceutiques been actively publishing?

Actualites Pharmaceutiques has been in operation since 1961 till date.

What is the publishing frequency of Actualites Pharmaceutiques ?

Actualites Pharmaceutiques published with a Monthly frequency.

How many articles did Actualites Pharmaceutiques publish last years ?

In 2023, Actualites Pharmaceutiques published 267 articles.

What is the eISSN & pISSN for Actualites Pharmaceutiques ?

For Actualites Pharmaceutiques,eISSN is 0515-3700 and pISSN is0515-3700.

What is Citescore for Actualites Pharmaceutiques ?

Citescore for Actualites Pharmaceutiques is 0.1.

What is SNIP score for Actualites Pharmaceutiques ?

SNIP score for Actualites Pharmaceutiques is 0.15.

What is the SJR for Actualites Pharmaceutiques ?

SJR for Actualites Pharmaceutiques is Q4.

Who is the publisher of Actualites Pharmaceutiques ?

ELSEVIER MASSON, CORPORATION OFFICE is the publisher of Actualites Pharmaceutiques.